Authors:
THOGERSEN AM
JANSSON JH
BOMAN K
NILSSON TK
WEINEHALL L
HUHTASAARI F
HALLMANS G
Citation: Am. Thogersen et al., HIGH PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE-PLASMINOGEN ACTIVATORLEVELS IN PLASMA PRECEDE A FIRST ACUTE MYOCARDIAL-INFARCTION IN BOTH MEN AND WOMEN - EVIDENCE FOR THE FIBRINOLYTIC SYSTEM AS AN INDEPENDENTPRIMARY RISK FACTOR, Circulation, 98(21), 1998, pp. 2241-2247
Authors:
NILSSON JB
NILSSON TK
JANSSON JH
BOMAN K
THOGERSEN AM
NASLUND U
Citation: Jb. Nilsson et al., RELATIONSHIP BETWEEN FIBRINOLYTIC-ACTIVITY FOLLOWING STREPTOKINASE TREATMENT IN ACUTE MYOCARDIAL-INFARCTION AND VECTORCARDIOGRAPHIC SIGNS OF REPERFUSION, Fibrinolysis & proteolysis, 11(4), 1997, pp. 193-199
Citation: Am. Thogersen et al., MAGNESIUM THERAPY, FIBRINOLYTIC PARAMETERS AND VON-WILLEBRAND-FACTOR IN ACUTE MYOCARDIAL-INFARCTION, International journal of cardiology, 56(1), 1996, pp. 53-59
Authors:
NILSSON TK
THOGERSEN AM
JANSSON JH
BOMAN K
Citation: Tk. Nilsson et al., COMPARISON OF VON-WILLEBRAND-FACTOR AND TISSUE-PLASMINOGEN ACTIVATOR CONCENTRATIONS IN PLASMA AND SERUM, Clinical chemistry, 42(6), 1996, pp. 976-977
Citation: Am. Thogersen et al., EFFECTS OF INTRAVENOUS MAGNESIUM-SULFATE IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION ON ACUTE ARRHYTHMIAS AND LONG-TERM OUTCOME, International journal of cardiology, 49(2), 1995, pp. 143-151
Citation: Am. Thogersen et al., EFFECTS OF MAGNESIUM INFUSION ON THROMBOLYTIC AND NON-THROMBOLYTIC TREATED PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, International journal of cardiology, 39(1), 1993, pp. 13-22